Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus
All resent international and national guidelines for the treatment of patients with arterial hypertension offer a unified approach to the prescription of antihypertensive therapy. The vast majority of patients, including those with diabetes mellitus, require combined drugs. Renin-angiotensin-aldoste...
Guardado en:
Autores principales: | Juliya V. Zhernakova, Irina E. Chazova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Morozov P.V.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4175c06298d7460393727b5ac2732b25 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders
por: Nikita B. Perepech, et al.
Publicado: (2021) -
Full spectrum and genetic algorithm-selected spectrum-based chemometric methods for simultaneous determination of azilsartan medoxomil, chlorthalidone, and azilsartan: Development, validation, and application on commercial dosage form
por: Darwish Hany W., et al.
Publicado: (2021) -
Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease
por: Irina E. Chazova, et al.
Publicado: (2020) -
The place of fixed antihypertensive drugs in modern therapy of arterial hypertension
por: Tatiana V. Pinchuk, et al.
Publicado: (2021) -
Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future
por: Tamila V. Martynyuk, et al.
Publicado: (2021)